Daraxonrasib Resistance in Pancreatic Cancer May Yield to Allele-Specific Salvage Therapy
AACR work describes allele-specific resistance mechanisms to daraxonrasib in pancreatic cancer and explores salvage strategies to bypass treatment escape.
Therapeutics, diagnostics and evidence shaping cancer care.
Therapeutics, diagnostics and evidence shaping cancer care.